GreenMark Biomedical Secures Follow-On Investment
August 24, 2020 – GreenMark Biomedical Inc. announced that the company raised $1.74M in equity financing in the form of convertible notes in anticipation of a Series A financing in 2021
Read MoreAugust 24, 2020 – GreenMark Biomedical Inc. announced that the company raised $1.74M in equity financing in the form of convertible notes in anticipation of a Series A financing in 2021
Read MoreSeptember 8, 2021 – GreenMark Biomedical Inc. announced the company has been selected as a 2021 Cellerant Best of Class Technology Award recipient. “During what is once again proving to be a very challenging year for the dental industry, each of these extraordinary companies and their award winning technologies have earned the right to celebrate. I […]
Read MoreMay 20, 2020 – GreenMark Biomedical Inc. along with its collaborators at the University of Michigan (U-M) today announced that its technology on regenerative treatment of tooth enamel has received support at up to $913,000 from the Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center (NIH grant number: U24-DE029462).
Read MoreEast Lansing and Ann Arbor, MI – October 2, 2019 – GreenMark Biomedical Inc. today announced it has been awarded a $1.5m Phase II Small Business Innovation Research (SBIR) grant to further develop its patented nanoparticle-based dental technology for detection of early stage dental caries. The 2-year project involves collaboration with dental and biomaterials experts at […]
Read MoreAnn Arbor, MI – October 3, 2018 – GreenMark Biomedical Inc. today announced it secured funding for its patented dental technology that identifies ‘pre-cavities’ which can be treated non-invasively before becoming cavities. This will have major implications for treatment of tooth decay prior to the need for surgical treatment, resulting in improved oral health outcomes for […]
Read MoreAnn Arbor, MI – June 29, 2018 – GreenMark Biomedical Inc. today announced that it closed on $500K in equity investment. The round is led by BlueWater Angel Investment Network (BWA) of Saginaw, MI and funds flowed in May and June as part of a Rolling Close. Biosciences Research & Commercialization Center (BRCC), an early stage […]
Read MoreLansing, MI – June 10, 2016 – GreenMark Biomedical Inc. today announced an agreement relating to the transfer of certain intellectual property from EcoSynthetix Inc. (TSX: ECO), a renewable chemicals company that produces a portfolio of biobased products. GreenMark, a Delaware start-up corporation with facilities in Michigan, was formed for the purpose of delivering health benefits […]
Read More